王乐今，教授，主任医师，博士生导师。北京大学人民医院石家庄眼科医院院长、国家自然科学基金重大仪器项目首席科学家，中国医师协会斜视与小儿眼科副主任委员，美国眼科学会国际委员，美国斜视与小儿眼科国际委员，北京眼科学会副主任委员，北京眼视光学会主任委员，中共中央保健委员会专家及项目评审专家，国家药监局器械审评中心创新技术评审专家，加拿大多伦多大健康研究院专家，民族医药学会眼科分会副会长。在Science、 Nature Genetics、Circulation、 Am J of Med Genetics、Am J of Human Genetics、Mol vision等杂志上发表30余篇文章，被引频次总计4080，H-index=27。拥有自主知识产权项目11项，其中6项发明专利。作为项目负责人获得国家级、省部级及其它课题二十多项，其中有七项国家自然科学基金，总经费超过一千二百多万。获得2016年北京市科学技术三等奖及2016年亚太眼科学会防盲杰出贡献奖。

Lejin Wang is the professor and chief physician in the Department of Ophthalmology at Peking University People's Hospital. He is the president of Shijiazhuang Eye Hospital of Peking University People's Hospital, the chief scientist of the National Natural Science Foundation of China's major instrument project, the vice chairman of the Strabismus and Pediatric Ophthalmology Committee of the Chinese Medical Doctor Association, an international member of the American Academy of Ophthalmology, an international member of the American Association for Pediatric Ophthalmology and Strabismus, the vice chairman of the Beijing Ophthalmology Society, the chairman of the Beijing Ophthalmic Optometry Society, an expert and project review expert of the Central Political Bureau Health Care Committee, an innovation technology review expert of the National Medical Products Administration's Device Evaluation Center, an expert of the Toronto Institute of Health Sciences in Canada, and the vice chairman of the Ophthalmology Branch of the National Medical Ethnic Medicine Association. More than 30 articles have been published in journals such as Science, Nature Genetics, Circulation, Am J of Med Genetics, Am J of Human Genetics, and Mol vision, with a total citation frequency of 4,080 and an H-index of 27. Eleven projects with independent intellectual property rights have been owned, among which six are invention patents. As the project leader, more than 20 projects at the national, provincial and ministerial levels and other levels have been obtained, including seven National Natural Science Foundation projects, with a total budget of over 12 million. The 2016 Beijing Science and Technology Award for the Third Prize and the 2016 Asia-Pacific Ophthalmology Society Award for Outstanding Contribution to Blindness Prevention were received.